These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16301353)

  • 21. Towards the second generation of skeletal myoblasts?
    Menasché P
    Cardiovasc Res; 2008 Aug; 79(3):355-6. PubMed ID: 18508855
    [No Abstract]   [Full Text] [Related]  

  • 22. Coronary hemodynamics and myocardial oxygen consumption during support with rotary blood pumps.
    Voitl P; Vollkron M; Bergmeister H; Wieselthaler G; Schima H
    Artif Organs; 2009 Jan; 33(1):77-80. PubMed ID: 19178445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure.
    Watanabe T; Takeda T; Omiya S; Hikoso S; Yamaguchi O; Nakano Y; Higuchi Y; Nakai A; Abe Y; Aki-Jin Y; Taniike M; Mizote I; Matsumura Y; Shimizu T; Nishida K; Imai K; Hori M; Shirasawa T; Otsu K
    J Am Coll Cardiol; 2008 Aug; 52(9):779-86. PubMed ID: 18718428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow.
    Saitoh S; Zhang C; Tune JD; Potter B; Kiyooka T; Rogers PA; Knudson JD; Dick GM; Swafford A; Chilian WM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2614-21. PubMed ID: 17023676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of ventricular asynchrony on myocardial perfusion.
    Kyriakides ZS; Manolis AG; Kolettis TM
    Int J Cardiol; 2007 Jun; 119(1):3-9. PubMed ID: 17056140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial glucose transport and utilization: a target for therapeutic intervention.
    Singh PP; Lago RM; Nesto RW
    Rev Cardiovasc Med; 2008; 9(2):106-10. PubMed ID: 18660731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiac insufficiency. New physiopathological approaches and therapeutic implications].
    Ceia F; Fonseca C; Pires M; Araújo V; Sales Luís A
    Acta Med Port; 1985 Jan; 6(1):31-7. PubMed ID: 3984787
    [No Abstract]   [Full Text] [Related]  

  • 28. Energetics of small hearts.
    van der Laarse WJ
    J Physiol; 2006 May; 573(Pt 1):1. PubMed ID: 16543261
    [No Abstract]   [Full Text] [Related]  

  • 29. [Energy metabolism in the failing heart].
    Chodorowski Z; Rybakowska I; Anand JS; Kaletha K
    Przegl Lek; 2009; 66(6):356-8. PubMed ID: 19788151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomeric dysfunction in heart failure.
    Hamdani N; Kooij V; van Dijk S; Merkus D; Paulus WJ; Remedios CD; Duncker DJ; Stienen GJ; van der Velden J
    Cardiovasc Res; 2008 Mar; 77(4):649-58. PubMed ID: 18055579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.
    Fragasso G
    Int J Clin Pract; 2007 Apr; 61(4):603-10. PubMed ID: 17394434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart.
    Fedak PW
    Semin Thorac Cardiovasc Surg; 2008; 20(2):87-93. PubMed ID: 18707639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the impact of intramyocardial implantation of stem cells on myocardial perfusion and contractility in patients with coronary heart disease concurrent with postinfarct cardiosclerosis and chronic heart failure].
    Rakhmat-Zade TM; Skridlevskaia EA; Samoĭlenko LA; Bugriĭ ME; Konopliannikov AG; Kolesnikova AI; Tripol'skaia LV; Veselova TN; Sinitsyn VE; Sergienko VB; Akchurin RS
    Vestn Rentgenol Radiol; 2006; (5):9-14. PubMed ID: 17694813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options.
    Mytas DZ; Stougiannos PN; Zairis MN; Foussas SG; Pyrgakis VN; Kyriazis IA
    J Diabetes Complications; 2009; 23(4):273-82. PubMed ID: 18413201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
    Lemmens K; Doggen K; De Keulenaer GW
    Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].
    Bielecka-Dabrowa A; Wierzbicka M; Goch JH
    Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Energetics of the failing heart: new insights using genetic modification in the mouse.
    Ingwall JS
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):839-47. PubMed ID: 17067106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nutritional and metabolic support of heart failure in the intensive care unit.
    Meltzer JS; Moitra VK
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):140-6. PubMed ID: 18301089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.